Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors

被引：1

作者：

Roschewski, Mark ^{[1
]}

Dunleavy, Kieron ^{[1
]}

机构：

[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 06期

关键词：

OCCULT LEPTOMENINGEAL DISEASE; NON-HODGKINS-LYMPHOMA; DOUBLE-HIT LYMPHOMA; RISK-FACTORS; ELDERLY-PATIENTS; RITUXIMAB; RELAPSE; INVOLVEMENT; PROPHYLAXIS; RECURRENCE;

D O I：

10.3109/10428194.2015.1016936

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1583 / 1584

页数：2

共 18 条

[1] Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma [J].

Abramson, Jeremy S. ;

Hellmann, Matthew ;

Barnes, Jeffrey A. ;

Hammerman, Peter ;

Toomey, Christiana ;

Takvorian, Tak ;

Muzikansky, Alona ;

Hochberg, Ephraim P. .

CANCER, 2010, 116 (18) :4283-4290

[2] Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination [J].

Benevolo, Giulia ;

Stacchini, Alessandra ;

Spina, Michele ;

Ferreri, Andres J. M. ;

Arras, Marcella ;

Bellio, Laura ;

Botto, Barbara ;

Bulian, Pietro ;

Cantonetti, Maria ;

Depaoli, Lorella ;

Di Renzo, Nicola ;

Di Rocco, Alice ;

Evangelista, Andrea ;

Franceschetti, Silvia ;

Godio, Laura ;

Mannelli, Francesco ;

Pavone, Vincenzo ;

Pioltelli, Pietro ;

Vitolo, Umberto ;

Pogliani, Enrico M. .

BLOOD, 2012, 120 (16) :3222-3228

[3] Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516-The Southwest Oncology Group [J].

Bernstein, Steven H. ;

Unger, Joseph M. ;

LeBlanc, Michael ;

Friedberg, Jonathan ;

Miller, Thomas P. ;

Fisher, Richard I. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) :114-119

[4] CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) [J].

Boehme, Volkmar ;

Schmitz, Norbert ;

Zeynalova, Samira ;

Loeffler, Markus ;

Pfreundschuh, Michael .

BLOOD, 2009, 113 (17) :3896-3902

[5]

Chapuy B, 2014, BLOOD, V124

[6] Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab [J].

Feugier, P ;

Virion, JM ;

Tilly, H ;

Haioun, C ;

Marit, G ;

Macro, M ;

Bordessoule, D ;

Recher, C ;

Blanc, M ;

Molina, T ;

Lederlin, P ;

Coiffier, B .

ANNALS OF ONCOLOGY, 2004, 15 (01) :129-133

[7] Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era [J].

Fletcher, Christopher D. ;

Kahl, Brad S. .

LEUKEMIA & LYMPHOMA, 2014, 55 (10) :2228-2240

[8] High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology [J].

Hegde, U ;

Filie, A ;

Little, RF ;

Janik, JE ;

Grant, N ;

Steinberg, SM ;

Dunleavy, K ;

Jaffe, ES ;

Abati, A ;

Stetler-Stevenson, M ;

Wilson, WH .

BLOOD, 2005, 105 (02) :496-502

[9] Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era [J].

Kumar, Anita ;

Vanderplas, Ann ;

LaCasce, Ann S. ;

Rodriguez, Maria A. ;

Crosby, Allison L. ;

Lepisto, Eva ;

Czuczman, Myron S. ;

Nademanee, Auayporn ;

Niland, Joyce ;

Gordon, Leo I. ;

Millenson, Michael ;

Zelenetz, Andrew D. ;

Friedberg, Jonathan W. ;

Abel, Gregory A. .

CANCER, 2012, 118 (11) :2944-2951

[10] Mechanisms of Disease: Aggressive Lymphomas. [J].

Lenz, Georg ;

Staudt, Louis M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) :1417-1429

← 1 2 →